Search | IOVS | ARVO Journals

Showing 1 – 20 of 35

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Remofuscin slows retinal thinning in Stargardt Disease (STGD1) – results from the Stargardt Remofuscin Treatment Trial (STARTT) a 2-year placebo-controlled study.

Tobias Peters; Katarina Stingl; Wolfgang Klein; Mario G Fsadni; Nils Meland; Patty P.A. Dhooge; Camiel Boon; Andrew Lotery; Maurizio Battaglia Parodi; Philipp Herrmann; Frank G Holz; Steffen Schmitz-Valckenberg; Philipp Möller; Carel C B Hoyng

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2205.

ARVO Annual Meeting Abstract June 2024

Perceived disease burden and attitudes regarding clinical research in patients with Pseudoxanthoma elasticum

Johannes Birtel; Iris M Harmsen; Kristina Pfau; Philipp Herrmann; Jeannette Ossewaarde-van Norel; Redmer van Leeuwen; Wilko Spiering; Peter Charbel Issa

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3092.

ARVO Annual Meeting Abstract June 2024

Evaluation of early photoreceptor affection following successful retinal detachment surgery

Sandrine H. Künzel; Josua Sassen; Marlene Sassmannshausen; Lukas Goerdt; Yannick Liermann; Raffael G. Liegl; Philipp Herrmann; Robert Finger; Thomas Ach; Frank G Holz; Sarah Thiele

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6480.

ARVO Annual Meeting Abstract June 2023

IMPG2 -related maculopathy

Johannes Birtel; Richard Caswell; Samantha R De Silva; Philipp Herrmann; Salwah Rehman; Andrew J Lotery; Omar Abdul Rahman Mahroo; Michel Michaelides; Andrew R Webster; Robert E MacLaren; Peter Charbel Issa

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4643.

ARVO Annual Meeting Abstract June 2023

Functional benefits of subretinal gene augmentation therapy with Voretigene Neparvovec for inherited retinal disease associated with biallelic mutations in RPE65

Birgit Lorenz; Markus N Preising; Johanna Pauline Scholz; Sandrine H. Künzel; Philipp Herrmann; Frank G Holz

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):987.

ARVO Annual Meeting Abstract June 2023

Longitudinal characterization of chorioretinal atrophies after subretinal gene augmentation therapy with Voretigene Neparvovec in RPE65 -mediated retinal degeneration

Sandrine H. Künzel; Marlene Sassmannshausen; Josua Sassen; Markus N Preising; Frank G Holz; Birgit Lorenz; Philipp Herrmann

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5006.

ARVO Annual Meeting Abstract June 2023

Anti-VEGF Treatment in Pseudoxanthoma Elasticum – Risk factors and Visual Outcome

Kristin Raming; Maximilian Pfau; Philipp Herrmann; Frank G Holz; Kristina Pfau

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):985.

ARVO Annual Meeting Abstract June 2023

Longitudinal analysis of Optical Coherence Tomography Angiography in Macular Telangiectasia Type 2

Lukas Goerdt; Julie Jungblut; Jose Luis Rodriguez; Kristina Hess; Philipp Herrmann; Frank G Holz; Maximilian Wilhelm Maria Wintergerst

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2540.

Retina February 2023

Choriocapillaris Flow Signal Impairment in Patients With Pseudoxanthoma Elasticum

PDF

Anne-Sophie Loewinger; Maximilian Pfau; Philipp Herrmann; Frank G. Holz; Kristina Pfau
TAGS: eye, fluid flow, impairment, photoreceptors, pseudoxanthoma elasticum, chief complaint, atrophic condition of skin, biological response modifiers, calcification
Invest. Ophthalmol. Vis. Sci.. 2023; 64(2):21. https://doi.org/10.1167/iovs.64.2.21

Includes: Supplemental Content

Retina February 2023

Repeatability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients With Recessive Stargardt Disease 1

PDF

Patty P.A. Dhooge; Philipp T. Möller; Nils Meland; Katarina Stingl; Camiel J. F. Boon; Andrew J. Lotery; Maurizio Battaglia Parodi; Philipp Herrmann; Wolfgang Klein; Mario G. Fsadni; Thomas H. Wheeler-Schilling; Frank G. Holz; Carel B. Hoyng; Steffen Schmitz-Valckenberg; for the Soraprazan Consortium
TAGS: autofluorescence, diagnostic imaging, multicenter studies, stargardt's disease, reading (activity), eye
Trans. Vis. Sci. Tech.. 2023; 12(2):1. https://doi.org/10.1167/tvst.12.2.1

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

The retinal phenotype in primary hyperoxaluria type 2 and 3

Johannes Birtel; Roselie M.H. Diederen; Philipp Herrmann; Sander F. Garrelfs; Bernd Hoppe; Peter Charbel Issa

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):614 – A0329.

ARVO Annual Meeting Abstract June 2022

Proliferation of intraretinal vessels and disease progression in Macular Telangiectasia Type 2 (MacTel)

Lukas Goerdt; Kristina Hess; Philipp Herrmann; Frank G Holz; Simone Tzaridis

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2668.

ARVO Annual Meeting Abstract June 2022

Multimodal widefield imaging for postoperative monitoring in patients treated with voretigene neparvovec

Philipp Herrmann; Birgit Lorenz; Johanna Pauline Scholz; Ralf Brinken; Markus N Preising; Kristina Küpper; Naike Cavriani; Laura Wirtz; Frank G Holz

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4400 – F0079.

ARVO Annual Meeting Abstract June 2022

Reliability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients with Stargardt Disease

Jeroen Adrianus Antonius Hendrikus Pas; Patty P.A. Dhooge; Philipp T. Möller; Katarina Stingl; Camiel J F Boon; Andrew J Lotery; Maurizio Battaglia Parodi; Philipp Herrmann; Wolfgang Klein; Mario G Fsadni; Thomas H. Wheeler-Schilling; Frank G Holz; Carel C B Hoyng; Steffen Schmitz-Valckenberg

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4098 – F0062.

ARVO Annual Meeting Abstract June 2021

Postreceptor Neuronal Degeneration in Pseudoxanthoma Elasticum

Kristina Hess; Kristin Raming; Peter Charbel Issa; Philipp Herrmann; Frank G Holz; Maximilian Pfau

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2181.

ARVO Annual Meeting Abstract June 2021

Occult retinopathy in patients with severe kidney disease: NPHP1 -associated ciliopathy

Johannes Birtel; Georg Spital; Marius Book; Sandra Habbig; Sören Bäumner; Vera Riehmer; Bodo B. Beck; David Rosenkranz; Hanno J. Bolz; Mareike Dahmer-Heath; Philipp Herrmann; Jens König; Peter Charbel Issa

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3235.

ARVO Annual Meeting Abstract June 2020

Comprehensive geno- and phenotyping in a complex pedigree including four different inherited retinal dystrophies

Johannes Birtel; Martin Gliem; Kristina Hess; Theresa H. Birtel; Frank G. Holz; Ulrich Zechner; Hanno J. Bolz; Philipp Herrmann

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2419.

Retina February 2020

Phenotypic Spectrum of the Foveal Configuration and Foveal Avascular Zone in Patients With Alport Syndrome

PDF

Kristina Hess; Maximilian Pfau; Maximilian W. M. Wintergerst; Karin U. Loeffler; Frank G. Holz; Philipp Herrmann
TAGS: hereditary nephritis, phenotype, stairs, eye, cohort studies
Invest. Ophthalmol. Vis. Sci.. 2020; 61(2):5. https://doi.org/10.1167/iovs.61.2.5

Articles December 2019

Functional Relevance and Structural Correlates of Near Infrared and Short Wavelength Fundus Autofluorescence Imaging in ABCA4 -Related Retinopathy

PDF

Philipp L. Müller; Johannes Birtel; Philipp Herrmann; Frank G. Holz; Peter Charbel Issa; Martin Gliem
TAGS: fundus autofluorescence imaging, retinal diseases, eye, diagnostic imaging
Trans. Vis. Sci. Tech.. 2019; 8(6):46. https://doi.org/10.1167/tvst.8.6.46

Includes: Supplemental Content

Low Vision September 2019

Binocular Inhibition of Reading in Macular Telangiectasia Type 2

PDF

Simone Tzaridis; Philipp Herrmann; Peter Charbel Issa; Simona Degli Esposti; Siegfried K Wagner; Marcus Fruttiger; Catherine Egan; Gary Rubin; Frank G. Holz; Tjebo F. C. Heeren
TAGS: eye, reading (activity), reading speed, scotoma, telangiectasis
Invest. Ophthalmol. Vis. Sci.. 2019; 60(12):3835-3841. https://doi.org/10.1167/iovs.18-26414

Includes: Supplemental Content

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Remofuscin slows retinal thinning in Stargardt Disease (STGD1) – results from the Stargardt Remofuscin Treatment Trial (STARTT) a 2-year placebo-controlled study.

Perceived disease burden and attitudes regarding clinical research in patients with Pseudoxanthoma elasticum

Evaluation of early photoreceptor affection following successful retinal detachment surgery

IMPG2 -related maculopathy

Functional benefits of subretinal gene augmentation therapy with Voretigene Neparvovec for inherited retinal disease associated with biallelic mutations in RPE65

Longitudinal characterization of chorioretinal atrophies after subretinal gene augmentation therapy with Voretigene Neparvovec in RPE65 -mediated retinal degeneration

Anti-VEGF Treatment in Pseudoxanthoma Elasticum – Risk factors and Visual Outcome

Longitudinal analysis of Optical Coherence Tomography Angiography in Macular Telangiectasia Type 2

Choriocapillaris Flow Signal Impairment in Patients With Pseudoxanthoma Elasticum

Repeatability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients With Recessive Stargardt Disease 1

The retinal phenotype in primary hyperoxaluria type 2 and 3

Proliferation of intraretinal vessels and disease progression in Macular Telangiectasia Type 2 (MacTel)

Multimodal widefield imaging for postoperative monitoring in patients treated with voretigene neparvovec

Reliability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients with Stargardt Disease

Postreceptor Neuronal Degeneration in Pseudoxanthoma Elasticum

Occult retinopathy in patients with severe kidney disease: NPHP1 -associated ciliopathy

Comprehensive geno- and phenotyping in a complex pedigree including four different inherited retinal dystrophies

Phenotypic Spectrum of the Foveal Configuration and Foveal Avascular Zone in Patients With Alport Syndrome

Functional Relevance and Structural Correlates of Near Infrared and Short Wavelength Fundus Autofluorescence Imaging in ABCA4 -Related Retinopathy

Binocular Inhibition of Reading in Macular Telangiectasia Type 2

To View More...

You must be signed into an individual account to use this feature.